Total Funding
$8.2M
Employee Range
11-50
Breye Therapeutics is a Danish biopharmaceutical company developing innovative oral treatments for retinal vascular diseases. Their cutting-edge solutions aim to revolutionize the management of these conditions, providing new hope for patients worldwide.
Breye Therapeutics data powered by:
Share
Breye Therapeutics data powered by:
Breye TherapeuticsOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
Breye TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
2nd
In Denmark
Top 100%out of 2 startups
National Rank
Share
4,088th
In United States
Top 47%out of 8869 startups
Regional Rank
Share
4,319th
In North America
Top 45%out of 9666 startups
Breye TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
2nd
In Denmark
Top 100%out of 2 startups
National Rank
Share
1,830th
In United States
Top 53%out of 3470 startups
Regional Rank
Share
1,913th
In North America
Top 52%out of 3719 startups
rankings by:
Breye TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
Breye TherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro